Therapanacea Sas radiology AI products

Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Which exact product, version and licensed modules are in the current offer?
Do related FDA submissions document the same scope, or different functions and versions?
Which costs, support obligations and local acceptance tests remain unresolved?

Prepare with a buyer guide:

Radiology AI pricing and total cost of ownership

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K253091

ART-Plan+ (v3.1.0)

Therapanacea Sas

Authorized purpose: ART-Plan+ assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K253091. This release combined Annotate, prostate SmartPlan, and AdaptBox for supported head-and-neck, breast or thorax, and male-pelvis offline adaptive workflows, and added structures without changing the core indication.

Modality: Radiotherapy Planning Imaging
Anatomy: Multi-region
Decision: 2025-12-23

FDA-cleared K242822

ART-Plan+ (v.3.0.0)

Therapanacea SAS

Authorized purpose: ART-Plan assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K242822. This release included Annotate and TumorBox contouring plus SmartPlan automatic prostate-plan generation for import into the treatment-planning system for dose calculation, review, and approval.

Modality: Radiotherapy Planning Imaging
Anatomy: Multi-region
Decision: 2025-02-25

Radiotherapy planning Prostate imaging Oncology quantification

FDA-cleared K234068

ART-Plan (v.2.2.0)

Therapanacea SAS

Authorized purpose: ART-Plan v2.2.0 assists trained radiation therapy professionals with multimodality contouring and registration, automatic treatment planning, synthetic CT, dose computation, and offline replanning assessment.

Modality: Radiotherapy Planning Imaging
Anatomy: Multi-region
Decision: 2024-04-22

Radiotherapy planning

FDA-cleared K230023

ART-Plan

Therapanacea SAS

Authorized purpose: ART-Plan v1.10.1 assists trained radiation therapy professionals with multimodality registration and reviewed CT or MR contouring; this release added 48 structures to existing localizations, including support relevant to lung SBRT workflows.

Modality: Radiotherapy Planning Imaging
Anatomy: Multi-region
Decision: 2023-04-19

Radiotherapy planning